Substance Use Disorders and Opioid Dependence
Research activity includes opioid use disorder and treatment support for people maintained on buprenorphine, with interest in reducing illicit substance use and improving recovery-related outcomes.
- Opioid use disorder
- Buprenorphine maintenance
- Illicit substance use
The sponsor’s trial portfolio also touches on the interaction between opioid-related pharmacology and emotional processing in healthy controls.
Endocrinology and Type 1 Diabetes
Clinical research in type 1 diabetes focuses on preserving residual beta cell function and maintaining endogenous insulin secretion in children with recent-onset disease.
- Type 1 diabetes
- Residual beta cell function
- Insulin secretion
This area reflects interest in early disease management and metabolic preservation.
Mental Health and Grief-Related Disorders
The sponsor supports studies in prolonged grief disorder, with attention to symptom reduction and the impact of targeted interventions on grief severity.
- Prolonged grief disorder
- Grief symptom scales
- Emotional distress
Related work also overlaps with emotional response research in healthy participants.
Behavioral Science, Decision-Making, and Gambling Disorder
Trials in healthy volunteers and participants with gambling disorder examine reward evaluation, risk-taking, delay discounting, goal-directed learning, and sensitivity to losses.
- Gambling disorder
- Reward processing
- Risk and loss sensitivity
These studies connect behavioural outcomes with neural substrates involved in decision-making.
Neuroscience, Pain, and Autonomic Signalling
Research interests include the effects of morphine and oxytocin on stress response, social interaction, peripheral sensory afferents, and inflammation-related sensory processing.
- Oxytocin
- Morphine
- Peripheral sensory afferents
Additional work involves fMRI and microneurography in healthy participants to examine brain–body interactions.
